Crizotinib-based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation.
Chen JJ, Jin JM, Gu WJ, Zhao Z, Yuan H, Zhou YD, Nagle DG, Xi QL, Zhang XM, Sun QY, Wu Y, Zhang WD, Luan X.
Chen JJ, et al. Among authors: gu wj.
Cancer Sci. 2023 May;114(5):1958-1971. doi: 10.1111/cas.15733. Epub 2023 Feb 7.
Cancer Sci. 2023.
PMID: 36692137
Free PMC article.